Petco Q2 2026 slides: sales stabilize, debt falls 15%

Petco Health and Wellness Company reported Q2 2026 financial results, indicating a stabilization in sales and a 15% drop in debt. The company's shares rose 8.75% in after-hours trading to $2.86, reflecting investor confidence in its turnaround. Net sales increased by a modest 0.05% year-over-year, while comparable sales grew by 0.6%, marking the second consecutive quarter of positive growth.

Adjusted EBITDA reached $122.2 million, up from $113.9 million in the previous quarter, with normalized gross margin remaining flat compared to the prior year's peak.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.